April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Macular dysfunction is common in both type 1 and type 2 diabetic patients without macular edema
Author Affiliations & Notes
  • Lea Querques
    University Hospital San Raffaele, Milan, Italy
  • Giuseppe Querques
    University Hospital San Raffaele, Milan, Italy
    Ophthalmology, University Paris Est Creteil, Creteil, France
  • Umberto Debenedetto
    University Hospital San Raffaele, Milan, Italy
  • Rosangela Lattanzio
    University Hospital San Raffaele, Milan, Italy
  • Enrico Borrelli
    University Hospital San Raffaele, Milan, Italy
  • Giacinto Triolo
    University Hospital San Raffaele, Milan, Italy
  • Gisella Maestranzi
    University Hospital San Raffaele, Milan, Italy
  • Giliola Calori
    University Hospital San Raffaele, Milan, Italy
  • Francesco Bandello
    University Hospital San Raffaele, Milan, Italy
  • Footnotes
    Commercial Relationships Lea Querques, None; Giuseppe Querques, None; Umberto Debenedetto, None; Rosangela Lattanzio, None; Enrico Borrelli, None; Giacinto Triolo, None; Gisella Maestranzi, None; Giliola Calori, None; Francesco Bandello, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 4416. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Lea Querques, Giuseppe Querques, Umberto Debenedetto, Rosangela Lattanzio, Enrico Borrelli, Giacinto Triolo, Gisella Maestranzi, Giliola Calori, Francesco Bandello; Macular dysfunction is common in both type 1 and type 2 diabetic patients without macular edema. Invest. Ophthalmol. Vis. Sci. 2014;55(13):4416.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To study retinal function in asymptomatic type 1 and 2 diabetic patients with nonproliferative diabetic retinopathy (NPDR) and no clinical signs of diabetic macular edema (DME).

Methods: Thirty-six consecutive type 1 and 2 diabetic patients with NPDR and no DME, and 28 healthy controls, underwent a complete ophthalmologic examination, including spectral-domain optical coherence tomography (SD-OCT) and microperimetry.

Results: Thirty-six consecutive type 1 and 2 diabetic patients with NPDR and no DME, and 28 healthy controls, underwent a complete ophthalmologic examination, including spectral-domain optical coherence tomography (SD-OCT) and microperimetry. Results: Seventy-one eyes (17 with type 1 and 19 with type 2 diabetes) were included in this study. Mean best-corrected visual acuity was 0.00±0.01 LogMAR and 0.00±0.02 LogMAR for type 1 and type 2 diabetic patients, respectively (p=0.075). Mean central foveal thickness (CFT) was 234.5 ±13.7 µm and 256.3 ±12.7 µm for type 1 and type 2 diabetes, respectively (p=0.04), the CFT was statistically different compared with the control groups (p=0.04 and p=0.01, respectively). Mean retinal sensitivity was 18.9±0.5 dB and 17.7±0.4 dB for type 1 and type 2 diabetes, respectively; it was statistically different compared with the control groups (p<0.0001 and p<0.0001, respectively).

Conclusions: We demonstrated a significantly reduced sensitivity in both types asymptomatic NPDR patients without DME compared with healthy controls, this reduction was greater in type 2 diabetic patients. CFT was increased in both diabetic groups compared with control groups, despite the absence of DME.

Keywords: 499 diabetic retinopathy • 550 imaging/image analysis: clinical • 507 electrophysiology: clinical  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×